Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Therapeutic delivery

• Publication date

  2010-06-25

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.4155/TDE.10.4PMID 22816125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Particle size analysis of nanocrystals: improved analysis method.

  2010cited by this paper
• Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.

  2010cited by this paper
• Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes.

  2010cited by this paper
• Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery

  2010cited by this paper
• Nanoparticles: A personal experience for formulating poorly water soluble drugs.

  2010cited by this paper
• Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics.

  2010cited by this paper
• Functional Delivery of siRNA in Mice Using Dendriworms

  2009cited by this paper
• Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.

  2009cited by this paper
• Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery.

  2009cited by this paper
• Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.

  2009cited by this paper
• Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.

  2009cited by this paper
• Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.

  2009cited by this paper
• Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles

  2009cited by this paper
• Kinetic solubility and dissolution velocity of rutin nanocrystals.

  2009cited by this paper
• Solubility of ocular therapeutic agents in self-emulsifying oils. I. Self-emulsifying oils for ocular drug delivery: solubility of indomethacin, aciclovir and hydrocortisone.

  2009cited by this paper
• Nanomedicines for ocular NSAIDs: safety on drug delivery.

  2009cited by this paper
• Biodegradable amphiphilic polymer–drug conjugate micelles

  2009cited by this paper
• Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.

  2009cited by this paper
• Role of block copolymer nanoconstructs in cancer therapy.

  2009cited by this paper
• Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review

  2009cited by this paper
• Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.

  2009cited by this paper
• Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization

  2009cited by this paper
• Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.

  2009cited by this paper
• New Strategy for Solubilization of poorly soluble drug- SEDDS

  2009cited by this paper
• Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels.

  2009cited by this paper
• Cyclosporine A-Loaded Solid Lipid Nanoparticles: Ocular Tolerance and In Vivo Drug Release in Rabbit Eyes

  2009cited by this paper
• Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

  2009cited by this paper
• Production and characterization of Hesperetin nanosuspensions for dermal delivery.

  2009cited by this paper
• Sustained Release and Permeation of Timolol from Surface-Modified Solid Lipid Nanoparticles through Bioengineered Human Cornea

  2009cited by this paper
• Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability.

  2009cited by this paper
• Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.

  2009cited by this paper
• Development of an oral rutin nanocrystal formulation.

  2009cited by this paper
• Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS).

  2009cited by this paper
• Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.

  2009cited by this paper
• Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS).

  2008cited by this paper
• Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil.

  2008cited by this paper
• Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®)

  2008cited by this paper
• Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.

  2008cited by this paper
• Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.

  2008cited by this paper
• Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm.

  2008cited by this paper
• Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.

  2008cited by this paper
• Polymeric micelles in oral chemotherapy.

  2008cited by this paper
• Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

  2008cited by this paper
• Novel Nanomaterials for Clinical Neuroscience

  2008cited by this paper
• Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.

  2008cited by this paper
• Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.

  2008cited by this paper
• Advances in lipid nanodispersions for parenteral drug delivery and targeting.

  2008cited by this paper
• Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology.

  2008cited by this paper
• Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.

  2008cited by this paper
• Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.

  2008cited by this paper
• A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets.

  2008cited by this paper
• Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds

  2008cited by this paper
• Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs.

  2008cited by this paper
• Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.

  2008cited by this paper
• Development of Effective Ocular Preparations of Antifungal Agents

  2008cited by this paper
• Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.

  2008cited by this paper
• Solid lipid nanoparticles for pulmonary delivery of insulin.

  2008cited by this paper
• Dendrimers as biopharmaceuticals: synthesis and properties.

  2008cited by this paper
• Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.

  2007cited by this paper
• Layer-by-layer assembled films of cellulose nanowires with antireflective properties.

  2007cited by this paper
• Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.

  2007cited by this paper
• Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.

  2007cited by this paper
• Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.

  2007cited by this paper
• Doxorubicin and beta-lapachone release and interaction with micellar core materials: experiment and modeling.

  2007cited by this paper
• Oral insulin delivery by means of solid lipid nanoparticles

  2007cited by this paper
• Improving the high variable bioavailability of griseofulvin by SEDDS.

  2007cited by this paper
• Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.

  2007cited by this paper
• Functionalized Micellar Systems for Cancer Targeted Drug Delivery

  2007cited by this paper
• Doxorubicin and β-Lapachone Release and Interaction with Micellar Core Materials: Experiment and Modeling

  2007cited by this paper
• Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.

  2007cited by this paper
• Oral lipid-based formulations : enhancing the bioavailability of poorly water-soluable drugs

  2007cited by this paper
• Lipid-Based Excipients for Oral Drug Delivery

  2007cited by this paper
• Influence of the Formulation for Solid Lipid Nanoparticles Prepared with a Membrane Contactor

  2006cited by this paper
• Experimental determination of the diffusion boundary layer width of micron and submicron particles.

  2006cited by this paper
• Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.

  2006cited by this paper
• New method for the effective production of ultrafine drug nanocrystals.

  2006cited by this paper
• Distance-dependent fluorescence quenching on gold nanoparticles ensheathed with layer-by-layer assembled polyelectrolytes.

  2006cited by this paper
• Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

  2006cited by this paper
• Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

  2006cited by this paper
• Biological assay challenges from compound solubility: strategies for bioassay optimization.

  2006cited by this paper
• Micellar Nanocarriers: Pharmaceutical Perspectives

  2006cited by this paper
• In Situ Evading of Phagocytic Uptake of Stealth Solid Lipid Nanoparticles by Mouse Peritoneal Macrophages

  2006cited by this paper
• Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib

  2006cited by this paper
• Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

  2006cited by this paper
• Oral solid lipid nanoparticle-based antitubercular chemotherapy.

  2005cited by this paper
• The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.

  2005cited by this paper
• Dendrimer-drug interactions.

  2005cited by this paper
• Dendrimer biocompatibility and toxicity.

  2005cited by this paper
• Physicochemical characterization of polymeric micelles constructed from novel amphiphilic polyphosphazene with poly(N-isopropylacrylamide) and ethyl 4-aminobenzoate as side groups.

  2005cited by this paper
• Preparation of solid lipid nanoparticles using a membrane contactor.

  2005cited by this paper
• Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.

  2005cited by this paper
• Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

  2005cited by this paper
• A New Process for Drug Loaded Nanocapsules Preparation Using a Membrane Contactor

  2005cited by this paper
• Characterization of dendrimers.

  2005cited by this paper
• Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.

  2005cited by this paper
• Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices.

  2005cited by this paper
• Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.

  2005cited by this paper
• Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.

  2005cited by this paper
• Solid lipid nanoparticles for parenteral drug delivery.

  2004cited by this paper
• Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.

  2004cited by this paper

• Targeted Therapy of Antibody-Induced Autoimmune Arthritis Using Peptide-Guided Nanoparticles

  2024cites this paper
• The Utility of Peptide Ligand-Functionalized Liposomes for Subcutaneous Drug Delivery for Arthritis Therapy

  2023cites this paper
• A review of the latest research medications and information on the inflammatory, molecular, pathological, and targeted aspects of breast cancer

  2022cites this paper
• Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective.

  2020cites this paper
• Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs.

  2020cites this paper
• Ethical issues in research and development of nanoparticles

  2020cites this paper
• A Method for Efficient Loading of Ciprofloxacin Hydrochloride in Cationic Solid Lipid Nanoparticles: Formulation and Microbiological Evaluation

  2018cites this paper
• Oral Administration of Nanoparticles-Based TB Drugs

  2017cites this paper
• Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.

  2016cites this paper
• Trends and methods for nanobased delivery for nutraceuticals

  2016cites this paper
• Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships.

  2014cites this paper
• An implantable sensor for disease detection and treatment

  2014cites this paper
• Development of Ciprofloxacin HCl-Based Solid Lipid Nanoparticles Using Ouzo Effect: An Experimental Optimization and Comparative Study

  2013cites this paper
• Nanostructured lipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions.

  2013cites this paper
• NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

  2013cites this paper
• Nanosized Drug Delivery for Enhancement of Oral Bioavailability

  2012cites this paper
• Solid Lipid Nanoparticles of a Water Soluble Drug, Ciprofloxacin Hydrochloride

  2012influential citation
• Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles.

  2011cites this paper